Online citations, reference lists, and bibliographies.
← Back to Search

Oral Methoxsalen Photochemotherapy For The Treatment Of Psoriasis: A Cooperative Clinical Trial.

J. Melski, L. Tanenbaum, J. Parrish, T. Fitzpatrick, H. Bleich
Published 1977 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Extensive psoriasis in 1,308 patients has been treated two or three times a week with oral 8-methoxypsoralen followed by high intensity, long-wave ultraviolet light (PUVA). Excluding 169 patients still under early treatment, psoriasis cleared in 88% and failed to clear in 3%. One percent dropped out due to complications of treatment, and 8% for other reasons. The twice-a-week schedule was superior for patients with lighter skin types. Once a remission was induced, there was no difference in its maintenance when patients were treated once a week, once every other week, or once every third week. Each of these schedules was superior to no maintenance treatment. Immediate side effect of the 45,000 treatments administered in the first 18 months of this study were uncommon, temporary, and generally mild. No clinically significant changes in laboratory screening or eye examinations attributable to PUVA have been uncovered.
This paper references



This paper is referenced by
10.18725/OPARU-1616
Prospektive Studie zum Vergleich der Wirksamkeit einer UVA-Photochemotherapie nach Photosensibilisierung mit 8-Methoxypsoralengel (PUVA-Gel) versus mit 8-Methoxypsoralenbad (PUVA-Bad)
B. Mueller (2009)
10.1111/j.1365-2133.1979.tb00017.x
DNA repair synthesis in human skin exposed to ultraviolet radiation used in PUVA (psoralen and UV‐A) therapy for psoriasis
S. C. Bishop (1979)
10.1016/S0190-9622(86)70005-4
Liver biopsies from patients with psoriasis related to photochemotherapy (PUVA): findings before and after 1 year of therapy in twelve patients. A blind study and review of literature on hepatotoxicity of PUVA.
A. Nyfors (1986)
10.1016/S0190-9622(88)70153-X
Cutaneous melanomas in patients treated with psoralens plus ultraviolet A. A case report and the experience of the PUVA Follow-up Study.
A. Gupta (1988)
10.1046/j.1365-2133.1996.d01-1067.x
Sunbed use in relation to phenotype, erythema, sunscreen use and skin diseases. A questionnaire survey among Swedish adolescents
C. Boldeman (1996)
10.1111/j.1365-2710.1994.tb00678.x
Therapeutic progress II: treatment of psoriasis
H. Lewis (1994)
10.1016/S0190-9622(99)70406-8
Duration of remission of psoriasis therapies.
J. Koo (1999)
PHOTO CHEMOTHERAPY OF CUTANEOUS DISORDERS
T. Anderson (1980)
10.1111/j.1751-1097.1980.tb04029.x
1,4‐DIPHENYLBUTADIYNE, A NEW NON‐PHOTODYNAMIC PHOTOTOXIC COMPOUND
J. Kagan (1980)
10.1111/j.1365-2133.1982.tb00898.x
Do freckles protect the skin from actinic damage?
P. Wilson (1982)
10.1016/S0190-9622(83)70032-0
Position paper—PUVA therapy
D. Bickers (1983)
10.1016/S0300-9084(85)80090-0
Photochemotherapy using pyridopsoralens.
L. Dubertret (1985)
10.1007/978-1-4899-0571-0_5
Ultraviolet Radiation Dosimetry and Measurement
B. Diffey (1986)
10.1016/S0190-9622(86)70066-2
Long-term use of psoralens and ultraviolet A for psoriasis: evidence for efficacy and cost savings.
R. Stern (1986)
10.1001/ARCHDERM.1992.01680170066008
Reticulated black solar lentigo ('ink spot' lentigo).
J. Bolognia (1992)
10.1111/j.1600-0781.2004.00125.x
Psoralen ultraviolet A therapy in 2004
W. Morison (2004)
10.1111/j.1365-2133.1991.tb00421.x
Melanocytic lesions and melanocyte populations in human epidermis
M. Fallowfield (1991)
10.1016/S0001-7310(04)76817-9
Fototerapia y fotoquimioterapia
J. Carrascosa (2004)
10.1056/NEJMCT072317
Psoralen and ultraviolet a light therapy for psoriasis.
R. Stern (2007)
10.1111/j.1365-2133.1978.tb01999.x
Induction of UV light tolerance by PUVA in patients with polymorphous light eruption
F. Gschnait (1978)
10.1016/S0190-9622(80)80116-2
The cardiovascular stress of photochemotherapy (PUVA).
R. Ciafone (1980)
10.1111/1523-1747.EP12464137
Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment.
R. Stern (1988)
10.1111/J.1600-0749.1991.TB00435.X
Dysplastic melanocytic nevi contain high levels of pheomelanin: quantitative comparison of pheomelanin/eumelanin levels between normal skin, common nevi, and dysplastic nevi.
T. Salopek (1991)
10.1016/S0190-9622(96)90325-4
Treatment of psoriasis with polyethylene sheet bath PUVA.
V. Streit (1996)
10.1111/j.1365-2133.1979.tb05622.x
Psoralen photochemotherapy of psoriasis
E. Hell (1979)
10.1111/j.1365-2133.1980.tb06552.x
The mitotic index in psoriatic plaques and their response to PUVA therapy
L. Goldberg (1980)
10.1111/j.1365-2133.1984.tb04635.x
Cutaneous carcinoma in psoriatic patients treated with PUVA
H. Reshad (1984)
10.1111/j.1365-2133.1995.tb02670.x
A comparison of twice‐weekly MPD‐PUVA and three times‐weekly skin typing‐PUVA regimens for the treatment of psoriasis
D. Buckley (1995)
10.1007/s13555-016-0130-9
The Patient’s Guide to Psoriasis Treatment. Part 2: PUVA Phototherapy
B. Farahnik (2016)
10.1080/00015550410025903
Frequency and distribution pattern of melanocytic naevi in Swedish 8-9-year-old children.
I. Synnerstad (2004)
10.18231/2581-4729.2018.0026
Comparison of two modalities of phototherapy, narrowband UV-B and PUVA in the treatment of psoriasis: A study from Western Uttar Pradesh
Amit Jaiswal (2018)
10.7326/0003-4819-88-3-349
Peritoneal dialysis for psoriasis. An uncontrolled study.
Z. Twardowski (1978)
See more
Semantic Scholar Logo Some data provided by SemanticScholar